Both in Biotechnology
Agenus vs Scribe Therapeutics
Over the past year AGEN returned −3.9% and SCTX returned −45.5%; their daily moves had a correlation of 0.15.
AGEN −3.9% SCTX −45.5%Growth of $1, one year, split-adjusted
| Metric | AGEN | SCTX |
|---|---|---|
| Price | $6.67 | $16.20 |
| Market cap | $301.2M | $306.7M |
| Today | +2.14% | +4.25% |
| 1 month | −23.6% | −0.1% |
| 6 months | +60.0% | — |
| Year to date | +112.4% | — |
| 1 year | +68.0% | — |
| Revenue growth (YoY) | +34.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | 3.3× | — |
| Price / sales | 2.3× | — |
| Net cash | -$11.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 88.6% | — |
| Short % of float | 16.6% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).